Human microbiome has a vast potential in several areas, including being a source of naturally evolved drug candidates. The importance of the microbiome for human health is enabled by technological advances in microbiology and genomics which lead to a rapid increase in interest and demand for cultivating microorganisms.
There is a big leap in isolating new species and strains of microorganisms. Cultivation of microorganisms of simple bacteria is being done widely in several areas. New companies emerge, addressing human health, creating breakthrough opportunities to develop novel therapeutics, next generation probiotics, etc. However, studying and deploying new and complex bacteria is often hindered by skills and experience in cultivating them at an industrial scale.
Our experts develop a flexible pipeline for cultivation procedure that takes 2-3 months (instead of 6 to 12 months).
The main uniqueness of our approach is to offer all services from DNA sequencing to development of industrially feasible bacteria in one pipeline, as an integrated service. Our approach to cultivation of microorganisms will combine a synergetic and high throughput pipeline of DNA sequencing methods, metabolic modelling, analytical (omics) methods and cultivation.